X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (30) 30
dermatology (23) 23
disabling pansclerotic morphea (23) 23
localized scleroderma (21) 21
scleroderma (18) 18
pansclerotic morphea (17) 17
index medicus (15) 15
female (14) 14
scleroderma, localized - pathology (14) 14
systemic scleroderma (14) 14
child (11) 11
scleroderma, localized - therapy (11) 11
male (10) 10
phototherapy (10) 10
rheumatology (10) 10
scleroderma, localized - diagnosis (10) 10
adult (9) 9
childhood (9) 9
children (9) 9
methotrexate (9) 9
morphea (9) 9
squamous-cell carcinoma (9) 9
systemic-sclerosis (8) 8
treatment (8) 8
generalized morphea (7) 7
immunosuppressive agents - therapeutic use (7) 7
linear scleroderma (7) 7
middle aged (7) 7
scleroderma, localized - complications (7) 7
scleroderma, localized - drug therapy (7) 7
severity of illness index (7) 7
treatment outcome (7) 7
care and treatment (6) 6
diagnosis (6) 6
disabling pansclerotic morphea of childhood (6) 6
juvenile localized scleroderma (6) 6
puva therapy (6) 6
skin (6) 6
squamous cell carcinoma (6) 6
adolescent (5) 5
child, preschool (5) 5
corticosteroids (5) 5
en-coup (5) 5
health aspects (5) 5
progressive facial hemiatrophy (5) 5
scleroderma, systemic - diagnosis (5) 5
skin - pathology (5) 5
uva (5) 5
versus-host-disease (5) 5
biopsy (4) 4
clinical trials as topic (4) 4
diagnosis, differential (4) 4
phototherapy - methods (4) 4
puva bath photochemotherapy (4) 4
aged (3) 3
atopic-dermatitis (3) 3
broad-band uva (3) 3
case studies (3) 3
classification (3) 3
combined modality therapy (3) 3
contracture - etiology (3) 3
coup-de-sabre (3) 3
disease progression (3) 3
features (3) 3
incidence (3) 3
intravascular calcinosis (3) 3
light therapy (3) 3
low-dose methotrexate (3) 3
medium-dose uva1 (3) 3
photochemotherapy (3) 3
risk assessment (3) 3
risk factors (3) 3
scleroderma, localized - physiopathology (3) 3
scleroderma, localized - radiotherapy (3) 3
sclerosis (3) 3
skin diseases (3) 3
skin neoplasms - etiology (3) 3
systemic sclerosis (3) 3
ultraviolet therapy (3) 3
young adult (3) 3
1st case series (2) 2
340-400 nm phototherapy (2) 2
analysis (2) 2
antirheumatic agents - therapeutic use (2) 2
autoantibodies (2) 2
biopsy, needle (2) 2
borrelia-burgdorferi infection (2) 2
cancer (2) 2
carcinoma, squamous cell - etiology (2) 2
carcinoma, squamous cell - pathology (2) 2
case series (2) 2
chimerism (2) 2
chronic ulcer (2) 2
contracture - pathology (2) 2
coumarins (2) 2
cyclophosphamide (2) 2
deep morphea (2) 2
development and progression (2) 2
disabled persons (2) 2
dose uva1 phototherapy (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Case Report - Unilateral linear pansclerotic morphea affecting face and limbs, 12/2005
Disabling pansclerotic morphea is a rare atrophying and sclerosing disorder of the subcutaneous tissue, muscle and bone. It is characterized by atrophy of the... 
Disabling pansclerotic morphea, Parry Romberg syndrome, Morphea, En coup de saber
Journal
Seminars in Cutaneous Medicine and Surgery, ISSN 1085-5629, 06/2007, Volume 26, Issue 2, pp. 90 - 95
Journal Article
Journal Article
Journal of Cutaneous Pathology, ISSN 0303-6987, 12/2015, Volume 42, Issue 12, pp. 929 - 936
Background The exact pathogenesis of morphea is poorly understood, and only a few clinical or histopathological studies have been conducted in Asian patients.... 
morphea | scleroderma | Korea | CLINICAL PRESENTATION | LOCALIZED SCLERODERMA | DISABLING PANSCLEROTIC MORPHEA | PATHOLOGY | SYSTEMIC-SCLEROSIS | EPIDEMIOLOGY | CHILDREN | DERMATOLOGY | Medicine, Experimental | Medical research | Systemic scleroderma | Analysis | Scleroderma (Disease)
Journal Article
Journal of Rheumatology, ISSN 0315-162X, 01/2014, Volume 41, Issue 1, pp. 106 - 112
Objective. Pansclerotic morphea is a poorly described form of morphea with little information on prevalence, demographics, and clinical features.... 
Morphea | Pansclerotic sclerosis | Localized scleroderma | PANSCLEROTIC SCLEROSIS | TRIAL | MORPHEA | LOCALIZED SCLERODERMA | INDEX | RHEUMATOLOGY | SYSTEMIC-SCLEROSIS | CHILDHOOD | Severity of Illness Index | Cross-Sectional Studies | Humans | Middle Aged | Male | Scleroderma, Localized - diagnosis | Young Adult | Time Factors | Sex Factors | Adult | Female | Registries | Aged | Child | Disabled Persons
Journal Article
RHEUMATOLOGY INTERNATIONAL, ISSN 0172-8172, 05/2019, Volume 39, Issue 5, pp. 933 - 941
Disabling pansclerotic morphea of childhood (DPMC) is a rare subtype of juvenile localized scleroderma (JLS) characterized by pansclerosis mainly affecting... 
Treatment | Disabling pansclerotic morphea of childhood | EFFICACY | LOCALIZED SCLERODERMA | SQUAMOUS-CELL CARCINOMA | METHOTREXATE | Children | PHOTOTHERAPY | RHEUMATOLOGY | Pediatric | FEATURES | Hydroxychloroquine - therapeutic use | Methylprednisolone - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Scleroderma, Systemic - pathology | Child, Preschool | Male | Scleroderma, Localized - diagnosis | Scleroderma, Localized - therapy | Scleroderma, Systemic - diagnosis | Scleroderma, Systemic - therapy | Scleroderma, Systemic - physiopathology | Treatment Failure | Prednisolone - therapeutic use | Skin - pathology | Antirheumatic Agents - therapeutic use | Biological Products - therapeutic use | Contracture - physiopathology | Scleroderma, Localized - physiopathology | Scleroderma, Localized - pathology | Hematopoietic Stem Cell Transplantation | Treatment Outcome | Synovitis - physiopathology | Mycophenolic Acid - therapeutic use | Immunoglobulins, Intravenous - therapeutic use | Janus Kinase Inhibitors - therapeutic use | Biopsy | Protein Kinase Inhibitors - therapeutic use | Edema - physiopathology | Immunologic Factors - therapeutic use | Tyrosine | Care and treatment | Corticosteroids | Systemic scleroderma | Scleroderma (Disease) | Development and progression | Transplantation | Hematopoietic stem cells | Phototherapy | Immunotherapy | Skin | Diagnosis | Mycophenolate mofetil | Methotrexate
Journal Article
The Journal of rheumatology, ISSN 0315-162X, 1/2014, Volume 41, Issue 1, pp. 106 - 112
Journal Article
Indian Journal of Dermatology, ISSN 0019-5154, 2014, Volume 59, Issue 3, pp. 316 - 316
Disabling pansclerotic morphea (DPM) is a rare, severe, and mutilating form of morphea, involving the dermis, subcutaneous tissue, fat, muscle, and even bone.... 
Adult | methotrexate | disabling pansclerotic morphea | systemic corticosteroids | systemic corncosteroids | DERMATOLOGY | Case studies | Care and treatment | Corticosteroids | Systemic scleroderma | Scleroderma (Disease) | Dosage and administration | Diagnosis | Methotrexate | Hematology | Light therapy | Scleroderma | Raynaud disease | Amputation | E-Case Report
Journal Article
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, ISSN 0151-9638, 12/2016, Volume 143, Issue 12, pp. 836 - 840
Background. - Pansclerotic morphea is a poorly described but extremely debilitating variant of localized scleroderma. We report a case with a rapidly fatal... 
JUVENILE LOCALIZED SCLERODERMA | Cyclophosphamide | Iloprost | Extracorporeal photopheresis | Corticosteroids | Methotrexate | Pansclerotic morphea | CHILDHOOD | CANCER | CHILDREN | FEATURES | DERMATOLOGY | Leg Ulcer - etiology | Sepsis - etiology | Scleroderma, Localized - complications | Humans | Cachexia - etiology | Fatal Outcome | Female | Child
Journal Article
Journal Article
Indian Journal of Dermatology, ISSN 0019-5154, 4/2013, Volume 58, Issue 2, pp. 159 - 159
Disabling pansclerotic morphea (DPM) of childhood is a rare generalized type of localized scleroderma (LS) that is known to follow an aggressive course with... 
juvenile localized scleroderma | Disabling pansclerotic morphea of childhood | extracutaneous manifestations | gangrene | Case studies | Care and treatment | Systemic scleroderma | Biopsy | Patient outcomes | Scleroderma (Disease) | Skin | Diagnosis | Health aspects | Risk factors | Scleroderma | Children & youth | E-Case Report
Journal Article
Indian dermatology online journal, ISSN 2229-5178, 04/2014, Volume 5, Issue 2, pp. 170 - 172
Morphea is a variant of localized scleroderma in which lesions are usually limited to the skin and subcutaneous tissue. Pansclerotic morphea is a rare... 
contracture | hemiatrophy | Pansclerotic morphea | Case Report
Journal Article
Journal Article